These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acyl-CoA synthetase short-chain family member 2 (ACSS2) is regulated by SREBP-1 and plays a role in fatty acid synthesis in caprine mammary epithelial cells. Xu H, Luo J, Ma G, Zhang X, Yao D, Li M, Loor JJ. J Cell Physiol; 2018 Feb; 233(2):1005-1016. PubMed ID: 28407230 [Abstract] [Full Text] [Related]
8. Dietary fructose feeds hepatic lipogenesis via microbiota-derived acetate. Zhao S, Jang C, Liu J, Uehara K, Gilbert M, Izzo L, Zeng X, Trefely S, Fernandez S, Carrer A, Miller KD, Schug ZT, Snyder NW, Gade TP, Titchenell PM, Rabinowitz JD, Wellen KE. Nature; 2020 Mar; 579(7800):586-591. PubMed ID: 32214246 [Abstract] [Full Text] [Related]
9. Inhibition of ATP citrate lyase induces triglyceride accumulation with altered fatty acid composition in cancer cells. Migita T, Okabe S, Ikeda K, Igarashi S, Sugawara S, Tomida A, Soga T, Taguchi R, Seimiya H. Int J Cancer; 2014 Jul 01; 135(1):37-47. PubMed ID: 24310723 [Abstract] [Full Text] [Related]
10. ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses. Kaymak I, Watson MJ, Oswald BM, Ma S, Johnson BK, DeCamp LM, Mabvakure BM, Luda KM, Ma EH, Lau K, Fu Z, Muhire B, Kitchen-Goosen SM, Vander Ark A, Dahabieh MS, Samborska B, Vos M, Shen H, Fan ZP, Roddy TP, Kingsbury GA, Sousa CM, Krawczyk CM, Williams KS, Sheldon RD, Kaech SM, Roy DG, Jones RG. J Exp Med; 2024 Sep 02; 221(9):. PubMed ID: 39150482 [Abstract] [Full Text] [Related]
11. ATP-citrate lyase deficiency in the mouse. Beigneux AP, Kosinski C, Gavino B, Horton JD, Skarnes WC, Young SG. J Biol Chem; 2004 Mar 05; 279(10):9557-64. PubMed ID: 14662765 [Abstract] [Full Text] [Related]
12. ATP-citrate lyase: a mini-review. Chypre M, Zaidi N, Smans K. Biochem Biophys Res Commun; 2012 May 25; 422(1):1-4. PubMed ID: 22575446 [Abstract] [Full Text] [Related]
13. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation. Zheng W, Tasselli L, Li TM, Chua KF. Genes (Basel); 2021 Sep 21; 12(9):. PubMed ID: 34573442 [Abstract] [Full Text] [Related]
14. ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer. Migita T, Narita T, Nomura K, Miyagi E, Inazuka F, Matsuura M, Ushijima M, Mashima T, Seimiya H, Satoh Y, Okumura S, Nakagawa K, Ishikawa Y. Cancer Res; 2008 Oct 15; 68(20):8547-54. PubMed ID: 18922930 [Abstract] [Full Text] [Related]
15. Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease. Guo L, Guo YY, Li BY, Peng WQ, Chang XX, Gao X, Tang QQ. J Biol Chem; 2019 Aug 02; 294(31):11805-11816. PubMed ID: 31197036 [Abstract] [Full Text] [Related]
19. ATP citrate lyase (ACLY) inhibitors: An anti-cancer strategy at the crossroads of glucose and lipid metabolism. Granchi C. Eur J Med Chem; 2018 Sep 05; 157():1276-1291. PubMed ID: 30195238 [Abstract] [Full Text] [Related]
20. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans. Che L, Chi W, Qiao Y, Zhang J, Song X, Liu Y, Li L, Jia J, Pilo MG, Wang J, Cigliano A, Ma Z, Kuang W, Tang Z, Zhang Z, Shui G, Ribback S, Dombrowski F, Evert M, Pascale RM, Cossu C, Pes GM, Osborne TF, Calvisi DF, Chen X, Chen L. Gut; 2020 Jan 05; 69(1):177-186. PubMed ID: 30954949 [Abstract] [Full Text] [Related] Page: [Next] [New Search]